Bracho-Blanchet E, Cortés-Sauza J, Dávila-Pérez R, Lezama VP, Villalobos-Alfaro C, Nieto-Zermeño J

Language: Spanish
References: 27
Page: 423-429
PDF size: 272.87 Kb.

ABSTRACT

Background: Central venous catheter (CVC) thrombosis in children is a main issue and its prevention with intravenous heparin is still controversial. The aim of this study was to evaluate efficacy of intravenous heparin in preventing CVC thrombosis both clinically and macroscopically.
Methods: We conducted a randomized clinical trial in a tertiary care children´s hospital with patients ‹18 years of age with CVC. Experimental group included addition of heparin at 2 IU/ml of intravenous fluids (IV), whereas the control group did not include heparin.
Results: Seventy six lumen of catheters were included, 38 in each group. Both groups were homogeneous in epidemiological variables. Macroscopic thrombus was found in 27 (35.5%) lumen of catheters. The group with heparin showed thrombus in 7.8% and 63% in the control group (p ‹0.0001 with relative risk (RR) of 20 and confidence interval (CI) at 95% (5.1-77.2). Clinical evaluation showed adequate flow in the IV of the heparin group in 94.7% and 57.8% in the control group (p ‹0.001). Blood return through the lumen of catheters with heparin was present in 86.8% and 42.1% in the control group (p ‹0.001). Mean time for catheters was 14.3 days. There were no side effects or prolonged partial thromboplastin time.
Conclusions: Heparin infusion at 2 IU/ml is safe and effective in preventing CVC thrombosis in children.

REFERENCES

1. Groff DB, Amhed N. Subclavian vein catheterization in the infant. J Pediatr Surg 1974;9:171-174.

2. Raad II, Luna M, M Khalil SM, Costerton JW, Lam C, Bodey GP. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 1994;271:1014-1016.

3. Chastre J, Cornud F, Bouchama A, Viau F, Benacerraf R, Gibert C. Thrombosis as a complication of pulmonary-artery catheterization via the internal jugular vein. N Engl J Med 1982;306:278-281.

4. Berman W Jr, Fripp RR, Yabek SM, Wernly J, Corlew S. Great vein and right atrial thrombosis in critically ill infants and children with central venous lines. Chest 1991;99:963-967.

5. David M, Andrew M. Venous thromboembolic complications in children. J Pediatr 1993;123:337-346.

6. Rupar DG, Herzog KD, Fisher MC, Long SS. Prolonged bacteremia with catheter-related central venous thrombosis. Am J Dis Child 1990;144:879-882.

7. Hoar PF. Wilson RM, Mangano DT, Avery GJ, Szarnicki RJ, Hill JD. Heparin bonding reduces thrombogenicity of pulmonary-artery catheters. N Engl J Med 1981;305:993-995.

8. Krafte-Jacobs B, Sivit CJ, Mejía R, Pollack MM. Catheter-related thrombosis in critically ill children: comparison of catheters with and without heparin bonding. J Pediatr 1995;126:50-54.

9. Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients. Ann Surg 1988;208:227-240.

10. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic and urologic surgery. N Engl J Med 1988;318:1162-1173.

11. Walker WJ, Mundall SL, Broderick HG, Prasad B, Kim J, Ravi JM. Systemic heparinization for femoral percutaneous coronary arteriography. N Engl J Med 1973;288:826-828.

12. Verghese A, Widrich WC, Arbeit RD. Central venous septic thrombophlebitis—the role of medical therapy. Medicine 1985;64:394-400.

13. McFair TJ, Dudley HAF. The local complications of intravenous therapy. Lancet 1959;274(7099):365-367.

14. Daniell HW. Heparin in the prevention of infusion phlebitis: a doubleblind controlled study. JAMA 1973;226:1317-1321.

15. Brismar B, Hardstedt C, Jacobson S, Kager L, Malmborg AS. Reduction of catheter-associated thrombosis in parenteral nutrition by intravenous heparin therapy. Arch Surg 1982;117:1196-1199.

16. Fabri PJ, Mirtallo JM, Ruberg RL, Kudsk KA, Denning DA, Ellison EC, et al. Incidence and prevention of thrombosis of the subclavian vein during total parenteral nutrition. Surg Gynecol Obstet 1982;155:238-240.

17. Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest 1998;113:165-171.

18. Bracho-Blanchet E, Dávila-Pérez R, Uriarte-Saldaña L, Montes-Tapia F, Reyes Retana-Valdés R, Ordorica-Flores R, et al. Estudio comparativo acerca del efecto de la heparina en la prevención de la trombosis de catéteres venosos centrales en pacientes pediátricos. Rev Mex Cir Ped 1999;6:51-60.

19. Sutor AH, Massicotte P, Leaker M, Andrew M. Heparin therapy in pediatric patients. Semin Thromb Hemost 1997;23:303-319.

20. Nuss R, Hays T, Manco-Johnson M. Efficacy and safety of heparin anticoagulation for neonatal renal vein thrombosis. Am J Pediatr Hematol Oncol 1994;16:127-131.

21. Wille-Jorgensen P, Rasmussen MS, Andersen BR, Borly L. Heparins and mechanical methods for thromboprophylaxis in colorectal surgery. Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD001217. DOI: 10.1002/14651858.CD001217

22. Barrington KJ. Umbilical artery catheters in the newborn: effects of heparin. Cochrane Database of Systematic Reviews 1999, Issue 1. Art. No.: CD000507. DOI: 10.1002/14651858.CD000507

23. Bracho-Blanchet E, Dávila-Pérez R, Uriarte-Saldaña L, Montes-Tapia F. Trombosis de catéteres venosos centrales en pediatría. Fisiopatogenia, diagnóstico, utilidad de la heparina. Bol Med Hosp Infant Mex 2001;58:181-187.

24. Eberhart RC, Clagett CP. Catheter coatings, blood flow, and biocompatibility. Semin Hematol 1991;28(4 suppl 7):42-48.

25. Peters WR, Bush WH Jr, McIntyre RD, Hill LD. The development of fibrin sheath on indwelling venous catheters. Surg Gynecol Obstet 1973;137:43-47.

26. Chang GY, Lueder FL, DiMichele DM, Radkowski MA, McWilliams LJ, Jansen RD, et al. Heparin and the risk of intraventricular hemorrhage in premature infants. J Pediatr 1997;131:362-366.

27. Shah PS, Kalyn A, Satodia P, Sunn MS, Parvez B, Daneman A, et al. A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (Heparin Infusion for PCVC) study. Pediatrics 2007;119:e284-e291.